(Q80727601)

English

Intravitreal bevacizumab (Avastin) as primary treatment for myopic choroidal neovascularization

scientific article published on 01 July 2007

Statements

Intravitreal bevacizumab (Avastin) as primary treatment for myopic choroidal neovascularization (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit